American Journal of Infection Control

During the COVID-19 pandemic, near-ubiquitous use of masks in community settings was recommended (1). However, personal protective equipment is considered to be one of the least effective hazard control measures due to their reliance on an individual

More than 17,000 healthcare providers worldwide have lost their lives due to Covid-19 infection and its complications, since the beginning of the pandemic (1,2). Currently, one year after the outbreak declaration, it is estimated that approximately

Staphylococcus aureus including methicillin-resistant S. aureus (MRSA) is a leading pathogen in infants in neonatal intensive care unit (NICUs).1,2 S. aureus infections are associated with substantial mortality3 and long term morbidity.3,4 Infections

Metrics to track and compare outpatient pediatric antibiotic prescribing are needed to improve antibiotic use and prevent unwanted consequences of antibiotic overuse. We have considered the impact and feasibility of available metrics and propose

As of April 12, 2021, there have been over 136 million confirmed cases of COVID-19 worldwide and 2,938,804 deaths.1 The United States alone has suffered over 562,080 of those deaths. Kentucky has had a total of 434,878 cases and 6,204 deaths although

In the manuscript titled, “Impact of the influenza vaccine on COVID-19 infection rates and severity,” Conlon et al. explored the relationship between influenza vaccination and positive COVID-19 test results among patients tested for COVID-19 within

Infection prevention and control (IPC) precautions help to decrease microbial transmission, and through the appropriate use of antibiotics Antimicrobial Stewardship (AMS) programs aim to decrease the prevalence and emergence of Antimicrobial

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus causing coronavirus disease 2019 (COVID-19), was initially described in Wuhan, China in late 2019.1 Infection with SARS-CoV-2 typically causes fever, cough, and

Primary prevention of Clostridioides (Clostridium) difficile infections (CDI) remains a leading clinical challenge due to the persistence of C. difficile spores, ease of transmission in health care settings and the prevalence of common risk factors